NEW YORK (GenomeWeb) – Great Basin Scientific today announced it has submitted its Shiga Toxin Direct Test to the US Food and Drug Administration for 510(k) review. 

The submission follows the successful completion of a clinical trial by the Salt Lake City-based firm that met all of its clinical objectives, Great Basin said. If cleared, the test will be the only stand-alone molecular test for detecting Shiga toxin-producing E. coli and the serotype O157 directly from a patient specimen, it added. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.

Sponsored by

This webinar will provide a first-hand look at how a leading pathology lab implemented a next-generation sequencing panel to capture comprehensive molecular tumor profiles.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.